IBDEI2M4 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1108,0)
 ;;=PARAPHILIC DISORDERS^25^93
 ;;^UTILITY(U,$J,358.4,1109,0)
 ;;=PERSONALITY DISORDERS^27^93
 ;;^UTILITY(U,$J,358.4,1110,0)
 ;;=CRIME/LEGAL SYSTEM PROBLEMS^7^93
 ;;^UTILITY(U,$J,358.4,1111,0)
 ;;=PSYCHOSOCIAL/PERSONAL/ENVIRONMENTAL^28^93
 ;;^UTILITY(U,$J,358.4,1112,0)
 ;;=RELATIONAL PROBLEMS^29^93
 ;;^UTILITY(U,$J,358.4,1113,0)
 ;;=SCHIZOPHRENIA/OTH PSYCHOTIC DISORDERS^30^93
 ;;^UTILITY(U,$J,358.4,1114,0)
 ;;=SEXUAL DYSFUNCTION^31^93
 ;;^UTILITY(U,$J,358.4,1115,0)
 ;;=SLEEP DISORDERS^32^93
 ;;^UTILITY(U,$J,358.4,1116,0)
 ;;=SUBSTANCE ABUSE-ALCOHOL^35^93
 ;;^UTILITY(U,$J,358.4,1117,0)
 ;;=SUBSTANCE ABUSE-AMPHETAMINE^36^93
 ;;^UTILITY(U,$J,358.4,1118,0)
 ;;=SUBSTANCE ABUSE-CANNABIS^38^93
 ;;^UTILITY(U,$J,358.4,1119,0)
 ;;=SUBSTANCE ABUSE-HALLUCINOGEN^40^93
 ;;^UTILITY(U,$J,358.4,1120,0)
 ;;=SUBSTANCE ABUSE-OPIOID^42^93
 ;;^UTILITY(U,$J,358.4,1121,0)
 ;;=SUBSTANCE ABUSE-PSYCHOACTIVE DRUGS^43^93
 ;;^UTILITY(U,$J,358.4,1122,0)
 ;;=SUBSTANCE ABUSE-SEDATIVE/HYPNOTIC^44^93
 ;;^UTILITY(U,$J,358.4,1123,0)
 ;;=SUBSTANCE ABUSE-TOBACCO^45^93
 ;;^UTILITY(U,$J,358.4,1124,0)
 ;;=SUBSTANCE ABUSE-COCAINE^39^93
 ;;^UTILITY(U,$J,358.4,1125,0)
 ;;=TRAUMA/STRESSOR-RELATED DISORDERS^46^93
 ;;^UTILITY(U,$J,358.4,1126,0)
 ;;=SUBSTANCE ABUSE-INHALANT^41^93
 ;;^UTILITY(U,$J,358.4,1127,0)
 ;;=INTELLECTUAL DISABILITIES^19^93
 ;;^UTILITY(U,$J,358.4,1128,0)
 ;;=CLINICAL RESEARCH PROGRAM^5^93
 ;;^UTILITY(U,$J,358.4,1129,0)
 ;;=SOMATOFORM DISORDERS^34^93
 ;;^UTILITY(U,$J,358.4,1130,0)
 ;;=DISRUPTIVE,IMPULSE-CONTROL DISORDERS^11^93
 ;;^UTILITY(U,$J,358.4,1131,0)
 ;;=ELIMINATION DISORDERS^15^93
 ;;^UTILITY(U,$J,358.4,1132,0)
 ;;=GAMBLING DISORDER^16^93
 ;;^UTILITY(U,$J,358.4,1133,0)
 ;;=OTHER MENTAL DISORDERS^24^93
 ;;^UTILITY(U,$J,358.4,1134,0)
 ;;=NEURODEVELOPMENTAL DISORDERS^21^93
 ;;^UTILITY(U,$J,358.4,1135,0)
 ;;=SUBSTANCE ABUSE-CAFFEINE^37^93
 ;;^UTILITY(U,$J,358.4,1136,0)
 ;;=NEW PATIENT^1^94
 ;;^UTILITY(U,$J,358.4,1137,0)
 ;;=ESTABLISHED PATIENT^2^94
 ;;^UTILITY(U,$J,358.4,1138,0)
 ;;=EDUCATION & TRAINING FOR SELF MANAGEMENT^3^94
 ;;^UTILITY(U,$J,358.4,1139,0)
 ;;=ABUSE AND NEGLECT^1^95
 ;;^UTILITY(U,$J,358.4,1140,0)
 ;;=ANXIETY DISORDERS^3^95
 ;;^UTILITY(U,$J,358.4,1141,0)
 ;;=BIPOLAR DISORDERS^4^95
 ;;^UTILITY(U,$J,358.4,1142,0)
 ;;=DELIRIUM^8^95
 ;;^UTILITY(U,$J,358.4,1143,0)
 ;;=DEMENTIA/NEUROCOGNITIVE DISORDERS^9^95
 ;;^UTILITY(U,$J,358.4,1144,0)
 ;;=DEPRESSIVE DISORDERS^10^95
 ;;^UTILITY(U,$J,358.4,1145,0)
 ;;=DISSOCIATIVE DISORDERS ^12^95
 ;;^UTILITY(U,$J,358.4,1146,0)
 ;;=EATING & FEEDING DISORDERS^13^95
 ;;^UTILITY(U,$J,358.4,1147,0)
 ;;=EDUCATIONAL/OCCUPATIONAL PROBLEMS^14^95
 ;;^UTILITY(U,$J,358.4,1148,0)
 ;;=GENDER DYSPHORIA^17^95
 ;;^UTILITY(U,$J,358.4,1149,0)
 ;;=HOUSING/ECONOMIC PROBLEMS^18^95
 ;;^UTILITY(U,$J,358.4,1150,0)
 ;;=MEDICATION-INDUCED MOVEMENT DISORDERS^20^95
 ;;^UTILITY(U,$J,358.4,1151,0)
 ;;=OBSESSIVE-COMPULSIVE & RELATED DISORDERS^22^95
 ;;^UTILITY(U,$J,358.4,1152,0)
 ;;=ORGANIC DISORDERS^23^95
 ;;^UTILITY(U,$J,358.4,1153,0)
 ;;=PERSONAL HX & CURRENT CIRCUMSTANCES^26^95
 ;;^UTILITY(U,$J,358.4,1154,0)
 ;;=ADHD^2^95
 ;;^UTILITY(U,$J,358.4,1155,0)
 ;;=COUNSELING/MED ADVICE^6^95
 ;;^UTILITY(U,$J,358.4,1156,0)
 ;;=SOCIAL ENVIRONMENT PROBLEMS^33^95
 ;;^UTILITY(U,$J,358.4,1157,0)
 ;;=PARAPHILIC DISORDERS^25^95
 ;;^UTILITY(U,$J,358.4,1158,0)
 ;;=PERSONALITY DISORDERS^27^95
 ;;^UTILITY(U,$J,358.4,1159,0)
 ;;=CRIME/LEGAL SYSTEM PROBLEMS^7^95
 ;;^UTILITY(U,$J,358.4,1160,0)
 ;;=PSYCHOSOCIAL/PERSONAL/ENVIRONMENTAL^28^95
 ;;^UTILITY(U,$J,358.4,1161,0)
 ;;=RELATIONAL PROBLEMS^29^95
